1.95 USD
+0.03 (+1.56%)
Last: Jan 30, 2026, 04:30 PM
Overall CBUS gets a fundamental rating of 2 out of 10. We evaluated CBUS against 525 industry peers in the Biotechnology industry. CBUS has a bad profitability rating. Also its financial health evaluation is rather negative. CBUS is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year CBUS has reported negative net income.
- CBUS had a negative operating cash flow in the past year.
- CBUS had negative earnings in each of the past 5 years.
- CBUS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- With a decent Return On Assets value of -36.01%, CBUS is doing good in the industry, outperforming 61.33% of the companies in the same industry.
- With a Return On Equity value of -235.91%, CBUS is not doing good in the industry: 70.29% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -36.01% | ||
| ROE | -235.91% | ||
| ROIC | N/A |
ROA(3y)-65.46%
ROA(5y)-69.14%
ROE(3y)-199.52%
ROE(5y)-185.43%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for CBUS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- CBUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for CBUS has been increased compared to 1 year ago.
- The number of shares outstanding for CBUS has been increased compared to 5 years ago.
- CBUS has a better debt/assets ratio than last year.
2.2 Solvency
- CBUS has an Altman-Z score of -3.97. This is a bad value and indicates that CBUS is not financially healthy and even has some risk of bankruptcy.
- CBUS has a Altman-Z score of -3.97. This is comparable to the rest of the industry: CBUS outperforms 43.62% of its industry peers.
- CBUS has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
- CBUS's Debt to Equity ratio of 0.00 is in line compared to the rest of the industry. CBUS outperforms 49.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.97 |
ROIC/WACCN/A
WACC8.86%
2.3 Liquidity
- CBUS has a Current Ratio of 1.28. This is a normal value and indicates that CBUS is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.28, CBUS is not doing good in the industry: 83.05% of the companies in the same industry are doing better.
- CBUS has a Quick Ratio of 1.28. This is a normal value and indicates that CBUS is financially healthy and should not expect problems in meeting its short term obligations.
- With a Quick ratio value of 1.28, CBUS is not doing good in the industry: 82.10% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 1.28 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 82.01% over the past year.
- The Revenue has decreased by -8.64% in the past year.
- Measured over the past years, CBUS shows a very negative growth in Revenue. The Revenue has been decreasing by -10.20% on average per year.
EPS 1Y (TTM)82.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-833.33%
Revenue 1Y (TTM)-8.64%
Revenue growth 3Y-45.26%
Revenue growth 5Y-10.2%
Sales Q2Q%-63.11%
3.2 Future
- Based on estimates for the next years, CBUS will show a very strong growth in Earnings Per Share. The EPS will grow by 20.85% on average per year.
- Based on estimates for the next years, CBUS will show a very strong growth in Revenue. The Revenue will grow by 129.07% on average per year.
EPS Next Y18.82%
EPS Next 2Y26.54%
EPS Next 3Y17.72%
EPS Next 5Y20.85%
Revenue Next Year-2.44%
Revenue Next 2Y42.01%
Revenue Next 3Y136.77%
Revenue Next 5Y129.07%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for CBUS. In the last year negative earnings were reported.
- Also next year CBUS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as CBUS's earnings are expected to grow with 17.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.54%
EPS Next 3Y17.72%
5. Dividend
5.1 Amount
- CBUS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
CIBUS INC / CBUS FAQ
Can you provide the ChartMill fundamental rating for CIBUS INC?
ChartMill assigns a fundamental rating of 2 / 10 to CBUS.
What is the valuation status of CIBUS INC (CBUS) stock?
ChartMill assigns a valuation rating of 0 / 10 to CIBUS INC (CBUS). This can be considered as Overvalued.
Can you provide the profitability details for CIBUS INC?
CIBUS INC (CBUS) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for CBUS stock?
The Earnings per Share (EPS) of CIBUS INC (CBUS) is expected to grow by 18.82% in the next year.